COMPASS Pathways Plc (CMPS)’ Psilocybin Therapy Hits Phase 3 Success in Depression
COMPASS Pathways Plc (NASDAQ:CMPS), a biotechnology company specializing in innovative mental health treatments, is developing COMP360, a psilocybin-based therapy in late-stage development for treatment...